Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 1 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Genomic characterization and immunotherapy for microsatellite instability-high in cholangiocarcinoma.
BMC Med. 2024 Jan 29;22(1):42. doi: 10.1186/s12916-024-03257-7.
BMC Med. 2024.
PMID: 38281914
Free PMC article.
Real-world efficacy and prognostic factors of lenvatinib plus PD-1 inhibitors in 378 unresectable hepatocellular carcinoma patients.
Yang X, Chen B, Wang Y, Wang Y, Long J, Zhang N, Xue J, Xun Z, Zhang L, Cheng J, Lei J, Sun H, Li Y, Lin J, Xie F, Wang D, Pan J, Hu K, Guan M, Huo L, Shi J, Yu L, Zhou L, Zhou J, Lu Z, Yang X, Mao Y, Sang X, Lu Y, Zhao H.
Yang X, et al.
Hepatol Int. 2023 Jun;17(3):709-719. doi: 10.1007/s12072-022-10480-y. Epub 2023 Feb 8.
Hepatol Int. 2023.
PMID: 36753026
Free PMC article.
Item in Clipboard
Clinicopathological characteristics and treatment outcomes of occult breast cancer: a population-based study.
Zhao Z, Zhang T, Yao Y, Lu X.
Zhao Z, et al.
BMC Surg. 2022 Apr 17;22(1):143. doi: 10.1186/s12893-022-01472-8.
BMC Surg. 2022.
PMID: 35430796
Free PMC article.
Item in Clipboard
Cite
Cite